AAAAAA

   
Results: 1-23 |
Results: 23
Use of screening studies to predict survival among patients who do not have chronic graft-versus-host disease at day 100 after bone marrow transplantation
Authors: Wagner, JL Flowers, MED Longton, G Storb, R Martin, P
Citation: Jl. Wagner et al., Use of screening studies to predict survival among patients who do not have chronic graft-versus-host disease at day 100 after bone marrow transplantation, BIOL BLOOD, 7(4), 2001, pp. 239-240
Relapse alter allogeneic bone marrow transplantation for refractory anemiais increased by shielding lungs and liver during total body irradiation
Authors: Anderson, JE Appelbaum, FR Schoch, G Barnett, T Chauncey, TR Flowers, MED Storb, R
Citation: Je. Anderson et al., Relapse alter allogeneic bone marrow transplantation for refractory anemiais increased by shielding lungs and liver during total body irradiation, BIOL BLOOD, 7(3), 2001, pp. 163-170
Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations: The experience in fourcenters
Authors: Storb, R Blume, KG O'Donnell, MR Chauncey, T Forman, SJ Deeg, HJ Hu, WW Appelbaum, FR Doney, K Flowers, MED Sanders, J Leisenring, W
Citation: R. Storb et al., Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations: The experience in fourcenters, BIOL BLOOD, 7(1), 2001, pp. 39-44
Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers.
Authors: Bensinger, WI Martin, PJ Storer, B Clift, R Forman, SJ Negrin, R Kashyap, A Flowers, MED Lilleby, K Chauncey, TR Storb, R Rowley, S Heimfeld, S Blume, K
Citation: Wi. Bensinger et al., Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers., N ENG J MED, 344(3), 2001, pp. 175-181
Haemopoietic stem cell transplantation for advanced polycythaemia vera or essential thrombocythaemia
Authors: Jurado, M Deeg, HJ Gooley, T Anasetti, C Chauncey, T Flowers, MED Myerson, D Storb, R Appelbaum, FR
Citation: M. Jurado et al., Haemopoietic stem cell transplantation for advanced polycythaemia vera or essential thrombocythaemia, BR J HAEM, 112(2), 2001, pp. 392-396
The significance of bcr-abl molecular detection in chronic myeloid leukemia patients "late," 18 months or more after transplantation
Authors: Radich, JP Gooley, T Bryant, E Chauncey, T Clift, R Beppu, L Edmands, S Flowers, MED Kerkof, K Nelson, R Appelbaum, FR
Citation: Jp. Radich et al., The significance of bcr-abl molecular detection in chronic myeloid leukemia patients "late," 18 months or more after transplantation, BLOOD, 98(6), 2001, pp. 1701-1707
Immunity of patients surviving 20 to 30 years after allogeneic or syngeneic bone marrow transplantation
Authors: Storek, J Joseph, A Espino, G Dawson, MA Douek, DC Sullivan, KM Flowers, MED Martin, P Mathioudakis, G Nash, RA Storb, R Appelbaum, FR Maloney, DG
Citation: J. Storek et al., Immunity of patients surviving 20 to 30 years after allogeneic or syngeneic bone marrow transplantation, BLOOD, 98(13), 2001, pp. 3505-3512
Administration of cyclosporine for 24 months compared with 6 months for prevention of chronic graft-versus-host disease: a prospective randomized clinical trial
Authors: Kansu, E Gooley, T Flowers, MED Anasetti, C Deeg, HJ Nash, RA Sanders, JE Witherspoon, RP Appelbaum, FR Storb, R Martin, PJ
Citation: E. Kansu et al., Administration of cyclosporine for 24 months compared with 6 months for prevention of chronic graft-versus-host disease: a prospective randomized clinical trial, BLOOD, 98(13), 2001, pp. 3868-3870
CD34 cell dose in granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell grafts affects engraftment kinetics and development of extensive chronic graft-versus-host disease after human leukocyte antigen-identical sibling transplantation
Authors: Zaucha, JM Gooley, T Bensinger, WI Heimfeld, S Chauncey, TR Zaucha, R Martin, PJ Flowers, MED Storek, J Georges, G Storb, R Torok-Storb, B
Citation: Jm. Zaucha et al., CD34 cell dose in granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell grafts affects engraftment kinetics and development of extensive chronic graft-versus-host disease after human leukocyte antigen-identical sibling transplantation, BLOOD, 98(12), 2001, pp. 3221-3227
Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation
Authors: Storek, J Dawson, MA Storer, B Stevens-Ayers, T Maloney, DG Marr, KA Witherspoon, RP Bensinger, W Flowers, MED Martin, P Storb, R Appelbaum, FR Boeckh, M
Citation: J. Storek et al., Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation, BLOOD, 97(11), 2001, pp. 3380-3389
Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects
Authors: McSweeney, PA Niederwieser, D Shizuru, JA Sandmaier, BM Molina, AJ Maloney, DG Chauncey, TR Gooley, TA Hegenbart, U Nash, RA Radich, J Wagner, JL Minor, S Appelbaum, FR Bensinger, WI Bryant, E Flowers, MED Georges, GE Grumet, FC Kiem, HP Torok-Storb, B Yu, G Blume, KG Storb, RF
Citation: Pa. Mcsweeney et al., Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects, BLOOD, 97(11), 2001, pp. 3390-3400
Granulocyte colony-stimulating factor given to donors before apheresis does not prevent aplasia in patients treated with donor leukocyte infusion forrecurrent chronic myeloid leukemia after bone marrow transplantation
Authors: Flowers, MED Leisenring, W Beach, K Riddell, S Radich, JP Higano, CS Rowley, SD Chauncey, TR Bensinger, WI Sanders, JE Anasetti, C Storb, R Wade, J Appelbaum, FR Martin, PJ
Citation: Med. Flowers et al., Granulocyte colony-stimulating factor given to donors before apheresis does not prevent aplasia in patients treated with donor leukocyte infusion forrecurrent chronic myeloid leukemia after bone marrow transplantation, BIOL BLOOD, 6(3A), 2000, pp. 321-326
Low B-cell and monocyte counts on day 80 are associated with high infection rates between days 100 and 365 after allogeneic marrow transplantation
Authors: Storek, J Espino, G Dawson, MA Storer, B Flowers, MED Maloney, D
Citation: J. Storek et al., Low B-cell and monocyte counts on day 80 are associated with high infection rates between days 100 and 365 after allogeneic marrow transplantation, BLOOD, 96(9), 2000, pp. 3290-3293
Prolonged fluconazole prophylaxis is associated with persistent protectionagainst candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of a randomized, placebo-controlled trial
Authors: Marr, KA Seidel, K Slavin, MA Bowden, RA Schoch, HG Flowers, MED Corey, L Boeckh, M
Citation: Ka. Marr et al., Prolonged fluconazole prophylaxis is associated with persistent protectionagainst candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of a randomized, placebo-controlled trial, BLOOD, 96(6), 2000, pp. 2055-2061
Cyclosporine (CSP) or CSP pins methylprednisolone for graft-versus-host-disease prophylaxis in patients with high-risk lymphohemopoietic malignancies: long-term follow-up of a randomized trial
Authors: Deeg, HJ Flowers, MED Leisenring, W Appelbaum, FR Martin, PJ Storb, RF
Citation: Hj. Deeg et al., Cyclosporine (CSP) or CSP pins methylprednisolone for graft-versus-host-disease prophylaxis in patients with high-risk lymphohemopoietic malignancies: long-term follow-up of a randomized trial, BLOOD, 96(3), 2000, pp. 1194-1195
Polyclonal hematopoiesis with variable telomere shortening in human long-term allogeneic marrow graft recipients
Authors: Mathioudakis, G Storb, R McSweeney, PA Torok-Storb, B Lansdorp, PM Brummendorf, TH Gass, MJ Bryant, EM Storek, J Flowers, MED Gooley, T Nash, RA
Citation: G. Mathioudakis et al., Polyclonal hematopoiesis with variable telomere shortening in human long-term allogeneic marrow graft recipients, BLOOD, 96(12), 2000, pp. 3991-3994
Thalidomide for treatment of patients with chronic graft-versus-host disease
Authors: Koc, S Leisenring, W Flowers, MED Anasetti, C Deeg, HJ Nash, RA Sanders, JE Witherspoon, RP Appelbaum, FR Storb, R Martin, PJ
Citation: S. Koc et al., Thalidomide for treatment of patients with chronic graft-versus-host disease, BLOOD, 96(12), 2000, pp. 3995-3996
Treatment of relapsed leukemia after unrelated donor marrow transplantation with unrelated donor leukocyte infusions
Authors: Porter, DL Collins, RH Hardy, C Kernan, NA Drobyski, WR Giralt, S Flowers, MED Casper, J Leahey, A Parker, P Mick, R Bate-Boyle, B King, R Antin, JH
Citation: Dl. Porter et al., Treatment of relapsed leukemia after unrelated donor marrow transplantation with unrelated donor leukocyte infusions, BLOOD, 95(4), 2000, pp. 1214-1221
High rates of Pneumocystis carinii pneumonia in allogeneic blood and marrow transplant recipients receiving dapsone prophylaxis
Authors: Souza, JP Boeckh, M Gooley, TA Flowers, MED Crawford, SW
Citation: Jp. Souza et al., High rates of Pneumocystis carinii pneumonia in allogeneic blood and marrow transplant recipients receiving dapsone prophylaxis, CLIN INF D, 29(6), 1999, pp. 1467-1471
Pathophysiology and treatment of graft-versus-host disease
Authors: Flowers, MED Kansu, E Sullivan, KM
Citation: Med. Flowers et al., Pathophysiology and treatment of graft-versus-host disease, HEMAT ONCOL, 13(5), 1999, pp. 1091
Hepatitis C virus infection and bone marrow transplantation: A cohort study with 10-year follow-up
Authors: Strasser, SI Myerson, D Spurgeon, CL Sullivan, KM Storer, B Schoch, HG Kim, S Flowers, MED McDonald, GB
Citation: Si. Strasser et al., Hepatitis C virus infection and bone marrow transplantation: A cohort study with 10-year follow-up, HEPATOLOGY, 29(6), 1999, pp. 1893-1899
A phase I-II clinical trial to evaluate removal of CD4 cells and partial depletion of CD8 cells from donor marrow for HLA-mismatched unrelated recipients
Authors: Martin, PJ Rowley, SD Anasetti, C Chauncey, TR Gooley, T Petersdorf, EW van Burik, J Flowers, MED Storb, R Appelbaum, FR Hansen, JA
Citation: Pj. Martin et al., A phase I-II clinical trial to evaluate removal of CD4 cells and partial depletion of CD8 cells from donor marrow for HLA-mismatched unrelated recipients, BLOOD, 94(7), 1999, pp. 2192-2199
Long-term follow-up of a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide for patients receiving allogeneic marrow transplants during chronic phase of chronic myeloid leukemia
Authors: Clift, RA Radich, J Appelbaum, FR Martin, P Flowers, MED Deeg, HJ Storb, R Thomas, ED
Citation: Ra. Clift et al., Long-term follow-up of a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide for patients receiving allogeneic marrow transplants during chronic phase of chronic myeloid leukemia, BLOOD, 94(11), 1999, pp. 3960-3962
Risultati: 1-23 |